HYPERION DEFI, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
HYPERION DEFI, INC. (HYPD) had Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued of $0 as of 2023-12-31, per its 10-K filed 2024-03-18.
Discontinued › Balance Sheet › Liabilities
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued · last filed 2024-03-18
- 2023-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
- 2022-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
- 2021-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
- 2020-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-18 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-18 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |